Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Sjogren's Syndrome
NCT03411850Phase 2Unknown
- Sponsor
- Arthritis and Rheumatism Associates
- Start
- May 2016
- Primary completion
- May 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in Sjogren's syndrome, sponsored by Arthritis and Rheumatism Associates. Status: unknown.
02
Drugs
abatacept
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT03411850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03411850.